105 related articles for article (PubMed ID: 15785042)
1. A new era in the management of psoriasis? Promises and facts.
Naldi L
Dermatology; 2005; 210(3):179-81. PubMed ID: 15785042
[TBL] [Abstract][Full Text] [Related]
2. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
Tzu J; Kerdel F
Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis therapy in real life: the need for registries.
Schmitt-Egenolf M
Dermatology; 2006; 213(4):327-30. PubMed ID: 17135739
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
[TBL] [Abstract][Full Text] [Related]
5. [Role of new biological therapy in psoriasis treatment].
Cortijo Cascajares S; García Rodríguez MP; Campo Angora M; Serrano Garrote O; Herreros de Tejada A
Farm Hosp; 2004; 28(3):192-200. PubMed ID: 15222873
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in medical dermatology.
Clark LN; Lebwohl M
Int J Dermatol; 2007 Oct; 46(10):1005-10. PubMed ID: 17910704
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
8. New therapies under development for psoriasis treatment.
García-Pérez ME; Stevanovic T; Poubelle PE
Curr Opin Pediatr; 2013 Aug; 25(4):480-7. PubMed ID: 23838833
[TBL] [Abstract][Full Text] [Related]
9. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.
Reich K; Griffiths CE
Arch Dermatol Res; 2008 Nov; 300(10):537-44. PubMed ID: 18784934
[TBL] [Abstract][Full Text] [Related]
10. Guidance on the diagnosis and clinical management of psoriasis.
Cohen SN; Baron SE; Archer CB;
Clin Exp Dermatol; 2012 May; 37 Suppl 1():13-8. PubMed ID: 22486764
[TBL] [Abstract][Full Text] [Related]
11. New horizons in the management of psoriasis: introduction.
Lebwohl M
Cutis; 1998 Feb; 61(2 Suppl):7. PubMed ID: 9787985
[No Abstract] [Full Text] [Related]
12. Use of biologic agents in pediatric psoriasis.
Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
14. [Psoriasis--clinical picture and current therapy].
Shakery K; Reich K
Med Monatsschr Pharm; 2009 Sep; 32(9):335-44; quiz 345-6. PubMed ID: 19795696
[TBL] [Abstract][Full Text] [Related]
15. New topical psoriasis treatment.
Holdcroft C
Nurse Pract; 1995 Mar; 20(3):15-6. PubMed ID: 7761036
[No Abstract] [Full Text] [Related]
16. Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.
Antoniou C; Stefanaki I; Stratigos A; Moustou E; Vergou T; Stavropoulos P; Avgerinou G; Rigopoulos D; Katsambas AD
Br J Dermatol; 2010 May; 162(5):1117-23. PubMed ID: 19906069
[TBL] [Abstract][Full Text] [Related]
17. Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination.
Nast A; Erdmann R; Pathirana D; Rzany B
J Eval Clin Pract; 2008 Oct; 14(5):803-6. PubMed ID: 19018914
[TBL] [Abstract][Full Text] [Related]
18. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
[No Abstract] [Full Text] [Related]
20. [What's new in dermatological treatments?].
Ortonne JP
Ann Dermatol Venereol; 2008 Dec; 135 Suppl 7():S360-70. PubMed ID: 19264212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
